April 29th, 2025: Lawsuit Claims Ozempic Caused Severe Vision Loss A new lawsuit has been filed outside the GLP-1 multidistrict litigation (MDL), alleging that Ozempic caused severe vision loss
For Wegovy Users Wegovy is specifically approved for weight management
These reports, while not constituting official recognition of a causal relationship, warrant acknowledgment in clinical practice
Rybelsus (7mg dose per tablet, 30 pills) in the U.S., Canada, Japan, the Netherlands, Sweden, and Switzerland
Patients: A total of 9650 adult patients with established CV disease without CKD (56.7%), CKD only (13%), or both CV disease and CKD (27%) were randomized 1:1 to receive semaglutide tablets 14 mg (n=4825) or placebo (n=4825) once daily, both in addition to standard-of-care treatments for glycemic control and CV risk factors including blood pressure medication, lipid-lowering agents, and antiplatelet/anticoagulant therapy